Citation: Pa. Cotter et al., ASYMPTOMATIC TRICYCLIC TOXICITY ASSOCIATED WITH DILTIAZEM, Irish journal of psychological medicine, 13(4), 1996, pp. 168-169
Citation: Pw. Raven et Nf. Taylor, EVIDENCE FOR INDEPENDENT MODULATION OF HUMAN 11-HSD AND 5-ALPHA 5-BETA REDUCTASE ACTIVITIES/, Endocrine research, 22(4), 1996, pp. 811-815
Citation: Pw. Raven et al., THE RELATIONSHIP BETWEEN THE EFFECTS OF METYRAPONE TREATMENT ON DEPRESSED MOOD AND URINARY STEROID PROFILES, Psychoneuroendocrinology, 21(3), 1996, pp. 277-286
Citation: Pw. Raven et al., EXTRAADRENAL EFFECTS OF METYRAPONE INCLUDE INHIBITION OF THE 11-OXOREDUCTASE ACTIVITY OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE - A MODEL FOR11-HSD-I DEFICIENCY, Clinical endocrinology, 43(5), 1995, pp. 637-644
Citation: Jp. Hinson et al., WHY WE SHOULD GIVE A QUALIFIED WELCOME TO OUABAIN - A WHOLE NEW FAMILY OF ADRENAL-STEROID HORMONES, Journal of Endocrinology, 146(3), 1995, pp. 369-372